-
-
-
-
-
-
-
ZyVersa Therapeutics, Inc. Announces Pricing of $5.0 Million Public Offering
-
-
-
-
-
-
-
ZyVersa Therapeutics (ZVSA) Announces New Peer-Reviewed Publication Reinforcing the Rationale for Inhibiting ASC Specks with IC 100
-
-
-
-
-
-
-
ZyVersa Therapeutics, Inc. Announces Closing of $11.0 Million Public Offering
-
-
-
-
-
-
-
Form S-1/A ZyVersa Therapeutics,
-
-
-
-
-
66,598 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

